SCHEMBL6581375

SCHEMBL6581375

Cc1ccc([N+](=O)[O-])c(C)c1COS(=O)(=O)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.40
TSHR P16473 5/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALDH1A1 P00352 4/20 0.36
MAPT P10636 1/20 0.34
TXNRD1 Q16881 2/20 0.33
CA1 P00915 1/20 0.33
GAA P10253 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
RECQL P46063 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PTPN1 P18031 1/20 0.32
HTT P42858 1/20 0.32
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6641853 0.83 TSHR (0.41) TSHRSMN1; SMN2TDP1ALDH1A1MAPT
SCHEMBL7603497 0.79 CA2 (0.45) CA2TSHRSMN1; SMN2TDP1ALDH1A1
SCHEMBL7392580 0.76 TSHR (0.40) TSHRSMN1; SMN2TDP1ALDH1A1MAPT
SCHEMBL1534226 0.71 ALDH1A1 (0.48) CA2TSHRALDH1A1HTT
SCHEMBL6962624 0.71 TSHR (0.41) CA2TSHRSMN1; SMN2TDP1ALDH1A1
SCHEMBL4471027 0.71 TDP1 (0.41) TSHRSMN1; SMN2TDP1ALDH1A1MAPT
SCHEMBL27676059 0.71 TDP1 (0.45) CA2TSHRSMN1; SMN2TDP1ALDH1A1
SCHEMBL14509415 0.71 APEX1 (0.39) TSHRSMN1; SMN2TDP1ALDH1A1MAPT
SCHEMBL11741640 0.71 TSHR (0.50) TSHRSMN1; SMN2TDP1ALDH1A1MAPT
SCHEMBL1584530 0.70 TSHR (0.48) TSHRSMN1; SMN2TDP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867432-B1 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists AVENTIS PHARMA GMBH (DE) 2004-06-09 EP disclosed
US-6211196-B1 8-BENZYLOXY-(TETRAHYDRO)QUINOLINE DERIVATIVES; LIVER CIRRHOSIS, ALZHEIMER*S DISEASE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-04-03 US disclosed
EP-0867432-A2 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-30 EP disclosed